AEVIA · Product information
NAD+
1,000 mg total per pen
Collection previewPrice to confirm
Availability to confirm
Purchasing is not yet available.

Approved visual concept · actual contents and accessories subject to final specification
Product information
About NAD+
Cellular coenzyme involved in oxidation–reduction reactions.
Compound identity and research context · Separate from the exact product specification
What it is
NAD+ is a coenzyme, not a peptide. It participates in cellular redox chemistry.
Biological target / research area
Cellular metabolism and NAD-related pathways.
What the research examined
Evidence context: human metabolism pilot
A small human pilot examined plasma and urine metabolites during an intravenous infusion.
Evidence limitations
This metabolic study does not establish anti-ageing, energy or cognitive benefits from AEVIA vials or pens. Precursor supplement studies are not interchangeable with NAD+ injections.
Selected references
- Pilot investigation of plasma and urine NAD+ metabolites during infusion (2019) ↗ · Reviewed 14/10/2026
Documents
Information, together.
Composition & specification
1,000 mg total per pen. The complete product specification is pending verification. No liquid volume, concentration or dose-per-click value is published.
Instructions & documents
Product-specific directions have not been released. Do not infer a dose from the pen image, selector display or total content. The device image does not authorise use. Request the applicable product documentation.
Storage, expiry & safety
Storage conditions, expiry, in-use stability and disposal instructions must be confirmed for the exact product. Contact the AEVIA team for its documentation.
We’re here to help.
Questions about your label or product information? Contact the AEVIA team.
support@aevia.global ↗